Bottom line
What is BMSTX's expense ratio?
BMSTX's expense ratio is 0.84%, or about $84 a year on every $10,000 invested. That is cheaper than 57% of mid-cap funds we track (median 0.88%). It has no front-end sales load. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Sep 25, 2026
BMSTX fee table
| Net expense ratio | 0.84% |
|---|---|
| Gross expense ratio | 0.88% |
| Management fee | 0.49% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.14% |
| Fee waiver / reimbursement | -0.04% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Sep 25, 2026
What BMSTX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| BMSTX | $86 | $277 | $484 | $1,081 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.84% expense ratio costs roughly $47,200 in lost growth, versus about $49,300 for the median mid-cap fund (0.88%).